Event Type
Disclosure
Mandatory
Variant
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 5,
and in Exhibit 99.1 shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act, or the Exchange Act, whether ma
Financial Statements and Exhibits. Exhibit Number Description 10.1 Letter Agreement, dated July 21, 2025 by and between SAB Biotherapeutics, Inc. and RA Capital